Skip to main content
Caplight Logo









Entomal Biotech

Entomal Biotech

Private
Kuala LumpurEnergy & Sustainabilityhttps://entomal.com/

Last Round

Pre Seed

Aug 30, 2024

Total Funding Raised

$400,000

Company Overview

Entomal Biotech is a biotechnology company that specializes in biowaste treatment and organic by-product upcycling using Black Soldier Fly larvae to produce sustainable animal feed and organic fertilizer.

Sector

Energy & Sustainability

Verticals

Waste Management, Circular Economy, Biotechnology, Sustainable Materials

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting, Hardware Sales, Data as a Service

AI Layer

Application

Keywords

black soldier flyBSFinsect farmingwaste-to-valueorganic waste managementinsect proteincircular economyorganic fertilizerfrassdecentralized waste managementinsect feedcontainerized bioconversionagritechESG datainsect tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Entomal Biotech Comparables

Compare Entomal Biotech with similar companies based on industry and business-model similarity.

Entomal Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Flybox
85%
Better Origin
81%
LIVIN farms
81%

Entomal Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedAug 30, 2024
CrowdfundingFeb 13, 2023

Key People

Founding team and executive leadership

Yanni Xinyan Ching

Co-founder & Chief Commercial Officer (CCO)

Founding Team

Entomal Biotech Investors

Notable investors and investment history

Entomal Biotech investors
InvestorRounds
Leave a Nest CapitalPre Seed
144 VenturesPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 16, 2025

    Grew 43% QoQ, from 7 to 10 employees.

  • May 2, 2025

    Monthly visitors increased 127% MoM.

Entomal Biotech Filings

Explore SEC and related filing metadata, where available.

Entomal Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Entomal Biotech's valuation, stock price, and market status.

Is Entomal Biotech a public or private company?

Entomal Biotech is a private company.

What is the current stock price of Entomal Biotech?

Entomal Biotech is a private company with no public stock price. No recent secondary market data is available.

How much is Entomal Biotech worth (valuation)?

Valuation information for Entomal Biotech is not publicly available.

Can I buy Entomal Biotech stock?

Entomal Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Entomal Biotech's last funding round?

Entomal Biotech's most recent funding round was Pre Seed on August 30, 2024.

Who are the main investors in Entomal Biotech?

Key investors in Entomal Biotech include Leave a Nest Capital, 144 Ventures.

Will Entomal Biotech IPO soon?

No public IPO plans have been announced for Entomal Biotech.

How can I track Entomal Biotech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Entomal Biotech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersKuala Lumpur
Employee Range5
Year Founded2019
Last FundingAug 30, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?